FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2342094689> ?p ?o ?g. }

• W2342094689 endingPage "6263" @default.
• W2342094689 startingPage "6248" @default.
• W2342094689 abstract "ecto-5'-Nucleotidase (eN, CD73) catalyzes the hydrolysis of extracellular AMP to adenosine. eN inhibitors have potential for use as cancer therapeutics. The eN inhibitor α,β-methylene-ADP (AOPCP, adenosine-5'-O-[(phosphonomethyl)phosphonic acid]) was used as a lead structure, and derivatives modified in various positions were prepared. Products were tested at rat recombinant eN. 6-(Ar)alkylamino substitution led to the largest improvement in potency. N(6)-Monosubstitution was superior to symmetrical N(6),N(6)-disubstitution. The most potent inhibitors were N(6)-(4-chlorobenzyl)- (10l, PSB-12441, Ki 7.23 nM), N(6)-phenylethyl- (10h, PSB-12425, Ki 8.04 nM), and N(6)-benzyl-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] (10g, PSB-12379, Ki 9.03 nM). Replacement of the 6-NH group in 10g by O (10q, PSB-12431) or S (10r, PSB-12553) yielded equally potent inhibitors (10q, 9.20 nM; 10r, 9.50 nM). Selected compounds investigated at the human enzyme did not show species differences; they displayed high selectivity versus other ecto-nucleotidases and ADP-activated P2Y receptors. Moreover, high metabolic stability was observed. These compounds represent the most potent eN inhibitors described to date." @default.
• W2342094689 created "2016-06-24" @default.
• W2342094689 creator A5011853443 @default.
• W2342094689 creator A5012961044 @default.
• W2342094689 creator A5017915434 @default.
• W2342094689 creator A5030794161 @default.
• W2342094689 creator A5032059683 @default.
• W2342094689 creator A5033568795 @default.
• W2342094689 creator A5036684172 @default.
• W2342094689 creator A5039852181 @default.
• W2342094689 creator A5050544457 @default.
• W2342094689 creator A5051837204 @default.
• W2342094689 creator A5061278872 @default.
• W2342094689 creator A5074577709 @default.
• W2342094689 date "2015-07-30" @default.
• W2342094689 modified "2023-09-30" @default.
• W2342094689 title "α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective <i>ecto</i>-5′-Nucleotidase (CD73) Inhibitors" @default.
• W2342094689 cites W1513653241 @default.
• W2342094689 cites W1564690392 @default.
• W2342094689 cites W1591198417 @default.
• W2342094689 cites W1782568954 @default.
• W2342094689 cites W1792542720 @default.
• W2342094689 cites W1969233019 @default.
• W2342094689 cites W1969693767 @default.
• W2342094689 cites W1970013864 @default.
• W2342094689 cites W1972906179 @default.
• W2342094689 cites W1976374524 @default.
• W2342094689 cites W1978885991 @default.
• W2342094689 cites W1983654099 @default.
• W2342094689 cites W1990589855 @default.
• W2342094689 cites W1993178518 @default.
• W2342094689 cites W1995321301 @default.
• W2342094689 cites W2003598902 @default.
• W2342094689 cites W2005459694 @default.
• W2342094689 cites W2007879519 @default.
• W2342094689 cites W2008624230 @default.
• W2342094689 cites W2010428132 @default.
• W2342094689 cites W2011553843 @default.
• W2342094689 cites W2026003140 @default.
• W2342094689 cites W2029887979 @default.
• W2342094689 cites W2034626351 @default.
• W2342094689 cites W2044636894 @default.
• W2342094689 cites W2048773587 @default.
• W2342094689 cites W2050053784 @default.
• W2342094689 cites W2050678001 @default.
• W2342094689 cites W2051638077 @default.
• W2342094689 cites W2053908301 @default.
• W2342094689 cites W2055934028 @default.
• W2342094689 cites W2057884899 @default.
• W2342094689 cites W2058566085 @default.
• W2342094689 cites W2059124020 @default.
• W2342094689 cites W2060256979 @default.
• W2342094689 cites W2060691656 @default.
• W2342094689 cites W2062761137 @default.
• W2342094689 cites W2066318878 @default.
• W2342094689 cites W2074073537 @default.
• W2342094689 cites W2074631079 @default.
• W2342094689 cites W2074755975 @default.
• W2342094689 cites W2086335229 @default.
• W2342094689 cites W2087070363 @default.
• W2342094689 cites W2095988220 @default.
• W2342094689 cites W2099689816 @default.
• W2342094689 cites W2102478114 @default.
• W2342094689 cites W2104024807 @default.
• W2342094689 cites W2109244578 @default.
• W2342094689 cites W2113661022 @default.
• W2342094689 cites W2127825615 @default.
• W2342094689 cites W2151070736 @default.
• W2342094689 cites W2328548261 @default.
• W2342094689 cites W2332933023 @default.
• W2342094689 cites W2418348314 @default.
• W2342094689 cites W2949731546 @default.
• W2342094689 cites W2950528356 @default.
• W2342094689 cites W2952475344 @default.
• W2342094689 cites W91079099 @default.
• W2342094689 doi "https://doi.org/10.1021/acs.jmedchem.5b00802" @default.
• W2342094689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26147331" @default.
• W2342094689 hasPublicationYear "2015" @default.
• W2342094689 type Work @default.
• W2342094689 sameAs 2342094689 @default.
• W2342094689 citedByCount "103" @default.
• W2342094689 countsByYear W23420946892015 @default.
• W2342094689 countsByYear W23420946892016 @default.
• W2342094689 countsByYear W23420946892017 @default.
• W2342094689 countsByYear W23420946892018 @default.
• W2342094689 countsByYear W23420946892019 @default.
• W2342094689 countsByYear W23420946892020 @default.
• W2342094689 countsByYear W23420946892021 @default.
• W2342094689 countsByYear W23420946892022 @default.
• W2342094689 countsByYear W23420946892023 @default.
• W2342094689 crossrefType "journal-article" @default.
• W2342094689 hasAuthorship W2342094689A5011853443 @default.
• W2342094689 hasAuthorship W2342094689A5012961044 @default.
• W2342094689 hasAuthorship W2342094689A5017915434 @default.
• W2342094689 hasAuthorship W2342094689A5030794161 @default.
• W2342094689 hasAuthorship W2342094689A5032059683 @default.
• W2342094689 hasAuthorship W2342094689A5033568795 @default.
• W2342094689 hasAuthorship W2342094689A5036684172 @default.

• next